The U.S. Trade Representative (USTR) released its annual reports to Congress on China's and Russia's implementation of their World Trade Organization commitments. The 2018 reports sound the same alarms as previous reports and are critical of the unfair playing field both countries have created for foreign drugs and medical devices and the countries' lax intellectual property protections.